EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies

Clinical trial NCT02701907 · COMPLETED

Trial details

NCT number: NCT02701907
Sponsor: UNICANCER
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Cancers

Start date: 2016-12-01
Primary completion: 2021-04-17
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.